Summary
Defects in the APC-β-catenin pathway are common in colon cancer. We investigated whether aberrant regulation of upstream ligands stimulating this pathway occur in colon cancer. Using RNAase protection analysis, six out of eight wnt genes were expressed in 14 matched cases of normal, adenomatous and malignant colorectal tissues. Wnt 2 and wnt 5a were significantly up-regulated in the progression from normal through adenoma to carcinoma. Transcripts for wnts 4, 7b, 10b and 13, but not wnt 2 and wnt 5a were detected in several colorectal cell lines. In situ hybridization demonstrated that wnt 2 and wnt 5a transcripts were mainly in the lamina propria/stroma region with labelling predominantly in macrophages. Immunostaining with CD68 confirmed the wnt-expressing cells as macrophages. These results show a major difference in wnt expression in colon cancer compared to colon adenomas and suggest stromal wnt expression may play a role in tumour progression.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Austin, TW, Solar, GP, Ziegler, FC, Liem, L & Matthews, W (1997). A role for the wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89: 3624–3635.
Bilder, D, Graba, Y & Scott, MP (1998). Wnt and TGFβ signals subdivide the AbdA Hox domain during Drosophila mesoderm patterning. Development 125: 1781–1790.
Bui, TD, Zhang, L, Rees, MCP, Bicknell, R & Harris, AL (1997a). Expression and hormone regulation of wnt 2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer 75: 1131–1136.
Bui, T, Rankin, J, Smith, K, Huguet, EL & Harris, AL (1997b). Cloning and expression of human wnt 10b. Oncogene 11: 11–22.
Chomczynski, P & Sacchi, N (1987). Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
Dale, TC, Weber Hall, SJ, Smith, K, Huguet, EL, Jayatilake, H, Gusterson, BA, Shuttleworth, G, O’Hare, M & Harris, AL (1996). Compartment switching of WNT-2 expression in human breast tumors. Cancer Res 56: 4320–4323.
Fearon, ER & Vogelstein, B (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759–767.
Gavin, BJ, McMahon, JA & McMahon, AP (1990). Expression of multiple novel wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev 4: 2319–2332.
Groden, J, Thliveris, A, Samowitz, W, Carlson, M, Gelbert, L, Albertson, H, Joslyn, G, Stevens, J, Spirio, L, Robertson, M, Sargeant, L, Krapcho, K, Wolff, E, Burt, R, Hunghes, JP, Warrington, J, McPherson, J, Wasmuth, J, LePaslier, D, Abderrahim, H, Cohen, D, Leppert, M & White, R (1991). Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589–600.
Hart, MJ, de los Santos, R, Albert, IN, Rubinfeld, B & Polakis, P (1998). Downregulation of beta catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573–581.
Hinck, L, Nelson, WJ & Papkoff, J (1994). Wnt-1 modulates cell–cell adhesion in mammalian cells by stabilizing B-catenin binding to the cell adhesion protein cadherin. J Cell Biol 124: 729–724.
Huguet, EL, McMahon, JA, McMahon, AP, Bicknell, R & Harris, AL (1994). Differential expression of human wnt genes 2, 3, 4 and 7b in human breast cell lines and normal and disease states of human breast tissue. Cancer Res 54: 2615–2621.
Katoh, M, Hirai, M, Sugimura, T & Terada, M (1996). Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene family. Oncogene 13: 873–876.
Korinek, V, Barker, N, Morin, PJ, van Wichen, D, de Weger, R, Kinzler, KW, Vogelstein, B & Clevers, H (1997). Constitutive transcriptional activation by a B-catenin-Tcf complex in APC–/– colon carcinomas. Science 275: 1784–1787.
LeJeune, S, Huguet, EL, Hamby, A, Poulsom, R & Harris, AL (1995). Wnt 5a cloning, expression, and upregulation in human primary breast cancers. Clin Cancer Res 1: 215–222.
Miyoshi, Y, Ando, H, Nagase, H, Nishisho, I, Horii, A, Miki, Y, Mori, T, Utsunomiya, J, Baba, S, Petersen, G, Hamilton, SR, Lomzer, KW, Vogelstein, B & Nakamura, Y (1992). Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89: 4452–4456.
Morin, PJ, Sparks, AB, Korinek, V, Barker, N, Clevers, H, Vogelstein, B & Kinzler, KW (1997). Activation of B-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 275: 1787–1790.
Munemitsu, SI, Albert, B, Souza, B, Rubinfield, B & Polakis, P (1995). Regulation of intracellular B-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046–3050.
Nakagawa, H, Murata, Y, Koyama, K, Fujiyama, A, Miyoshi, Y, Monden, M, Akiyama, T & Nakamura, Y (1998). Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin. Cancer Res 15: 5176–5181.
Nakamura, T, Hamada, F, Ishidate, T, Anai, K, Kawahara, K, Toyoshima, K & Akiyama, T (1998). Axin, an inhibitor of the wnt signalling pathway, interacts with beta catenin, GSK-3beta and APC and reduces the beta catenin level. Genes Cells 3: 395–403.
Papkoff, J, Rubinfeld, B, Schryver, B & Polakis, P (1996). Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 16: 2128–2134.
Pennica, D, Swanson, TA, Welsh, JW, Roy, MA, Lawrence, DA, Lee, J, Brush, J, Taneyhill, LA, Deuel, B, Lew, M, Watanabe, C, Cohen, RL, Melhem, MF, Finley, GG, Qiurke, P, Goddard, AD, Hillan, KJ, Gurney, AL, Botstein, D & Levine, AJ (1999). Wisp genes are members of the connective-tissue growth-factor family that are upregulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95: 14717–14722.
Powell, SM, Zilz, N, Beazer-Barclay, Y, Bryan, TM, Hamilton, SR, Thibodeau, SN, Vogelstein, B & Kinzler, KW (1992). APC mutations occur early during colorectal tumorigenesis. Nature (London) 359: 235–237.
Pulford, KA, Rigney, EM, Micklem, KJ, Jones, M, Stross, WP, Gatter, KC & Mason, DY (1989). Kp1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42: 414–421.
Rocheleau, CE, Downs, WD, Lin, R, Wittmann, C, Bei, Y, Cha, YH, Ali, M, Priess, JR & Mello, CC (1997). Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos. Cell 90: 707–716.
Rubinfield, B, Souza, B, Albert, I, Munemitsu, S & Polakis, P (1995). The APC protein and E-cadherin form similar but independent complexes with a-catenin, B-catenin, and plakoglobin. J Biol Chem 270: 5549–5555.
Scott, PAE, Smith, K, Bicknell, R & Harris, AL (1997). A reliable external control for ribonuclease protection assays. Nucleic Acids Res 25: 1305–1306.
Senior, PV, Critchley, D, Beck, F, Walker, RA & Varley, JM (1988). The localisation of laminin mRNA and protein in the postimplantation embryo and placenta of mouse: an in situ hybridisation and immunohistochemical study. Development 104: 431–446.
Smith, KJ, Johnson, KA, Bryan, TM, Hill, DE, Markowitz, S, Willson, JKV, Paraskeve, C, Petersen, GM, Hamilton, SR, Vogelstein, B & Kinzler, KW (1993). The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90: 2846–2850.
Su, LK, Vogelstein, B & Kinzler, KW (1993). Association of the APC tumor suppressor protein with catenins. Science 262: 1734–1737.
Takebayashi, Y, Yamada, K, Miyadera, K, Sumizawa, Y, Furukawa, T, Kinoshita, F, Aoki, D, Okumura, H, Yamada, Y, Akiyama, S & Aikou, T (1997). The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32A: 1227–1232.
van Es, JH, Kirkpatrick, C, van de Wetering, M, Molenaar, M, Miles, A, Kuipers, J, Destree, O, Peifer, M & Clevers, H (1999). Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr Biol 9: 105–108.
Vider, BZ, Zimber, A, Chastre, E, Prevot, S, Gespach, C, Estlein, D, Wolloch, Y, Tronick, SR, Gazit, A & Yaniv, A (1996). Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 12: 153–158.
Zeng, L, Fagotto, F, Zhang, T, Hsu, W, Vasicek, TJ, Perry, WL 3rd, Lee, JJ, Tilghman, SM, Gumbiner, BM & Constantini, F (1997). The mouse fused locus encodes Axin, an inhibitor of the wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181–192.
Author information
Authors and Affiliations
Additional information
Correspondence to: K Smith
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Smith, K., Bui, T., Poulsom, R. et al. Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer 81, 496–502 (1999). https://doi.org/10.1038/sj.bjc.6690721
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690721
Keywords
This article is cited by
-
Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses
Journal of Translational Medicine (2021)
-
Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression
Cell Communication and Signaling (2020)
-
The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment
Cancer and Metastasis Reviews (2020)
-
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
Journal for ImmunoTherapy of Cancer (2019)
-
Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
Oncogene (2017)